Management

Hakkaart-van Roijen, L., Verboom, P., Philips, R. & Al, M.J. (2009).The cost utility of solifenacin in the threatment of overactive bladder.International Urology and Nephrology, 41, 293-298.Heesch, M.M. van, Bonsel G.J., Dumoulin, J.C., Evers, J.L.H., HoevenM.A.H.B.M. van der, Severens J.L., Dykgraaf RH.M., Veen, F. van der,Tonch, N., Nelen, W.L.D.M., Zonneveld, P. van, Goudoever, J.B. van,Tamminga, P., Steiner, K., Koopman-Esseboom, C., Beijsterveldt,C.E. van, Boomsma, D.I., Snellen, D., Dirksen, C.D. (2010). Long termcosts and effects of reducing the number of twin pregnancies in IVFby single embryo transfer: the TwinSing study. BMG Pediatrics, 10(75),1-11.Hendrix, A., Werf, C. van der, Bots, M.L., Birnie, E., Smagt, J.J. van der,Borleffs, C.J.W., Vink, A., Weert, H.C. van, Doevendans, P.A.F.M., Wilde,A.A.M., Mosterd, A. & Langen, I.M. van (2010). Rationale and design ofthe CAREFUL study. Netherlands Heart Journal, 18(6), 286-290.Hendrix, M., Pavlova, M., Nieuwenhuijze, M.J., Severens, J.L. & Nijhuis,J.G. (2010). Differences in preferences for obstetric care betweennulliparae and their partners in the Netherlands: a descrete-choiceexperiment. Journal of Psychosomatic Obstetrics and Gynecology,31(4), 243-251.Herk-Sukel, M.P.P. van, Poll-Franse, L.V. van de, Voogd, A.C.,Nieuwenhuijzen, G.A.P., Coebergh, J.W.W. & Herings, R.M.C. (2010).Half of breast cancer patients discontinue tamoxifen and anyendocrine treatment before the end of the recommended treatmentperiod of 5 years: a population-based analysis. Breast Cancer Researchand Treatment, 122(3), 843-851.Herk-Sukel, M.P.P. van, Poll-Franse, L.V. van de, Lemmens, V.E.P.P.,Vreugdenhil, G., Pruijt, J.F.M., Coebergh, J.W.W. & Herings, R.M.C.(2010). New opportunities for drug outcomes research in cancerpatients: The linkage of the Eindhoven Cancer Registry and thePHARMO Record Linkage System. European Journal of Cancer, 46(2),395-404.Hoogendoorn, E.J.I., Wetering, C.R. van, Schols, A.M.W.J. & Rutten-vanMölken, M.P.M.H. (2009). Self-report versus care provider registrationof healthcare utilization: impact on cost and cost-utility. InternationalJournal of Technology Assessment in Health Care, 25(4), 588-595.Hoogendoorn, E.J.I., Feenstra, T.L., Hoogenveen, R.T. & Rutten-vanMölken, M.P.M.H. (2010). Association between lung function andexacerbation frequency in patients with COPD. International Journalof COPD, 5, 435-444.Hoogendoorn, E.J.I., Wetering, C.R. van, Schols, A.M.W.J. & Rutten-vanMölken, M.P.M.H. (2010). Is INTERdisciplinary COMmunity-based COPDmanagement (INTERCOM) cost-effective? European RespiratoryJournal, 35(1), 79-87.75